With a complex web of technical, legal, ethical and informatic considerations to be taken into account it has never been more crucial to keep ahead in the latest developments in the biobanking field.

We bring together leaders from industry, academia and institutions from across the globe facilitating learning and development to maximise your research opportunities.

Representatives from GlaxoSmithKline, AstraZeneca, Merck, Sanofi-Aventis and many others highlight the newest and most innovative advances in the industry.